Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 202

Results For "NSE"

2557 News Found

Evusheld recommended for market authorisation in EU
Biotech | March 25, 2022

Evusheld recommended for market authorisation in EU

Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months


Seven ways the pharma industry can benefit from tech-driven logistics solutions
Opinion | March 24, 2022

Seven ways the pharma industry can benefit from tech-driven logistics solutions

The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable


Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


MedisimVR raises Rs 3.5 cr. in Pre-Series A round led by Inflection Point Ventures
Startup | March 24, 2022

MedisimVR raises Rs 3.5 cr. in Pre-Series A round led by Inflection Point Ventures

MedisimVR is a VR based medical education platform for doctors, nurses & allied health professionals. It aims to make comprehensive Virtual Reality medical simulation more accessible and affordable


Pfizer granted USFDA Breakthrough Therapy Designation for RSV vaccine candidate
Drug Approval | March 24, 2022

Pfizer granted USFDA Breakthrough Therapy Designation for RSV vaccine candidate

The FDA decision is primarily informed by the positive results of a proof-of-concept, Phase 2a study evaluating the safety, immunogenicity, and efficacy of a single dose of 120µg RSVpreF in a human viral challenge model in healthy adults 18 to 50 years of age


Arum Therapeutics implements CDD Vault to streamline research data
Biotech | March 23, 2022

Arum Therapeutics implements CDD Vault to streamline research data

Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers


Lonza appoints Christian Seufert as President of CHI Division
People | March 23, 2022

Lonza appoints Christian Seufert as President of CHI Division

Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


Merck’s Keytruda approved for fourth gynecologic cancer indication
Drug Approval | March 22, 2022

Merck’s Keytruda approved for fourth gynecologic cancer indication

The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial


Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health
News | March 22, 2022

Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health

Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now